FDA issued a Warning Letter to Altaire Pharmaceuticals, Inc. on 3/12/2020 for a later inspection.
483 Altaire Pharmaceuticals Jul 2002

483 Altaire Pharmaceuticals Jul 2002

Thomas Mooney FDA$119.00 - Available Now

FDA investigators audited the Altaire Pharmaceuticals - Aquebogue, NY, United States facility and issued inspectional observations (via FDA 483) on 25 Jul 2002.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Jul 2002
  • Location: Aquebogue, United States
  • FEI: 1000119582
Add To Cart